Sustainable and cost-effective monitoring of patients on ART

Abstract

A letter commending a research article (by Daniel Keebler and colleagues), which presented an economic analysis of three mathematical models to assess the costs and benefits of different strategies of clinical, CD4, and viral load monitoring for HIV-infected individuals on ART in three African countries with varying ART coverage and economies.

Citation

Gibb, D. M.; Mugyenyi, P. Sustainable and cost-effective monitoring of patients on ART. Lancet Global Health (2013) 2 (1) e4-e5. [DOI: 10.1016/S2214-109X(13)70081-0]

Sustainable and cost-effective monitoring of patients on ART

Updates to this page

Published 1 January 2013